We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
AUM
$654M
AUM Growth
+$197M
Cap. Flow
+$173M
Cap. Flow %
26.44%
Top 10 Hldgs %
5.37%
Holding
1,128
New
406
Increased
248
Reduced
183
Closed
278

Top Buys

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$3.79M
2
TPR icon
Tapestry
TPR
+$3.68M
3
GIS icon
General Mills
GIS
+$3.58M
4
WBD icon
Warner Bros
WBD
+$3.54M
5
GPN icon
Global Payments
GPN
+$3.53M

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Consumer Discretionary 16.19%
3 Industrials 15.71%
4 Healthcare 11.74%
5 Financials 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RESN
801
DELISTED
Resonant Inc.
RESN
$89K 0.01%
+27,648
New +$94.9K
VYGR icon
802
Voyager Therapeutics
VYGR
$183M
$88K 0.01%
+21,334
New +$96.7K
PCTI
803
DELISTED
PCTEL, Inc. Common Stock
PCTI
$86K 0.01%
+13,074
New +$87.7K
BPT
804
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$85K 0.01%
16,636
-13,195
-44% -$52.7K
LINC icon
805
Lincoln Educational Services
LINC
$1.33B
$84K 0.01%
10,770
-4,930
-31% -$35.2K
MNOV icon
806
MediciNova
MNOV
$65.5M
$84K 0.01%
+19,877
New +$85.6K
OSS icon
807
One Stop Systems
OSS
$303M
$84K 0.01%
+14,441
New +$81.6K
TAST
808
DELISTED
Carrols Restaurant Group, Inc.
TAST
$84K 0.01%
13,997
+1,167
+9% +$6.89K
ELOX
809
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$84K 0.01%
+1,056
New +$88.1K
ELVN icon
810
Enliven Therapeutics
ELVN
$3.92B
$83K 0.01%
+2,624
New +$81.4K
STSA
811
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$83K 0.01%
11,798
-2,110
-15% -$11.4K
CAAP icon
812
Corporacion America
CAAP
$4.21B
$82K 0.01%
14,256
-11,221
-44% -$61.3K
YCBD icon
813
cbdMD
YCBD
$5.32M
$82K 0.01%
79
-80
-50% -$95.7K
ALR
814
DELISTED
AlerisLife Inc
ALR
$82K 0.01%
14,317
+98
+0.7% +$558
BRY
815
DELISTED
Berry Corp
BRY
$81K 0.01%
12,000
+1,001
+9% +$6.33K
LSAK icon
816
Lesaka Technologies
LSAK
$396M
$81K 0.01%
17,149
-6,059
-26% -$31.6K
EXTN
817
DELISTED
Exterran Corporation
EXTN
$81K 0.01%
+17,077
New +$73.1K
LQDA icon
818
Liquidia Corp
LQDA
$7.48B
$80K 0.01%
+27,844
New +$77.1K
STEX
819
Streamex Corp
STEX
$74M
$77K 0.01%
1,988
+523
+36% +$19.5K
LJPC
820
DELISTED
La Jolla Pharmaceutical Company
LJPC
$77K 0.01%
18,095
-18
-0.1% -$77
HDSN
821
Hudson Technologies
HDSN
$254M
$76K 0.01%
+22,234
New +$53.6K
ONCT
822
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$76K 0.01%
800
+221
+38% +$26.2K
ATXS
823
DELISTED
Astria Therapeutics
ATXS
$74K 0.01%
+5,844
New +$75.9K
EPM icon
824
Evolution Petroleum
EPM
$132M
$74K 0.01%
+15,013
New +$59K
ASPU
825
DELISTED
ASPEN GROUP, INC.
ASPU
$74K 0.01%
+11,364
New +$64.8K

Similar funds

Occudo Quantitative Strategies's Q2 2021 Portfolio in Review

As of Q2 2021, Occudo Quantitative Strategies held 1,128 positions worth $654M, up 43% from $457M the previous quarter. Its ten largest holdings account for 5.4% of the portfolio.

Occudo Quantitative Strategies deployed $173M of net new capital in Q2 2021, opening 406 new positions and adding to 248 existing holdings. Its largest new stake was Fiserv Inc: 32,602 shares worth $3.48M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Tattooed Chef, Inc Class A Common Stock, an estimated $2.29M trimmed.

  • Occudo Quantitative Strategies's largest Q2 2021 buy was Fiserv Inc: 32,602 shares worth $3.48M.
  • Occudo Quantitative Strategies added most to Warner Bros in Q2 2021, an estimated $3.54M increase.
  • Occudo Quantitative Strategies's biggest Q2 2021 reduction was Tattooed Chef, Inc Class A Common Stock, cutting an estimated $2.29M.
  • Occudo Quantitative Strategies fully exited Xilinx Inc in Q2 2021, selling an estimated $2.58M.
  • Occudo Quantitative Strategies's ten largest holdings make up 5.4% of its $654M portfolio in Q2 2021.
  • Occudo Quantitative Strategies opened 406 new positions and closed 278 in Q2 2021.
  • Occudo Quantitative Strategies's portfolio value rose 43% quarter-over-quarter to $654M.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.